Samaha Eli — SEC Form 4 filings
SEC reporting owner CIK 1877589. 21 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-05-03 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 3,365,584 shares, $24,753,276 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 12 legs across 5 filings — 743,661 shares, $15,967,144 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 999,800 shares @ $8.75 ($8,748,250) in Theravance Biopharma, Inc., filed 2024-05-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | 10% owner | 4 | 3 legs · 2,498,924 sh · $20,915,775 | 5 legs · 343,661 sh · $5,910,952 | — |
| SYNOVUS FINANCIAL CORP | 10% owner | 3 | — | 7 legs · 400,000 sh · $10,056,192 | — |
| Stagwell Inc (STGW) | Director | 14 | 3 legs · 866,660 sh · $3,837,501 | — | 12 |
Form 4 filings — Samaha Eli
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 1,400 @ $17.04 · Sale (S): 5,564 @ $17.17 | EDGAR |
| 2026-07-02 | 4 | Stagwell Inc (STGW) | Grant/award (A): 2,691 @ $7.43 | EDGAR |
| 2026-07-01 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 273,871 @ $17.23 · Sale (S): 25,027 @ $17.13 · Sale (S): 37,799 @ $17.00 | EDGAR |
| 2026-06-12 | 4 | Stagwell Inc (STGW) | Grant/award (A): 22,970 @ $0 | EDGAR |
| 2026-04-02 | 4 | Stagwell Inc (STGW) | Grant/award (A): 3,180 @ $6.29 | EDGAR |
| 2026-01-05 | 4 | Stagwell Inc (STGW) | Grant/award (A): 4,090 @ $4.89 | EDGAR |
| 2025-10-02 | 4 | Stagwell Inc (STGW) | Grant/award (A): 3,552 @ $5.63 | EDGAR |
| 2025-07-01 | 4 | Stagwell Inc (STGW) | Grant/award (A): 4,444 @ $4.50 | EDGAR |
| 2025-06-16 | 4 | Stagwell Inc (STGW) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2025-06-06 | 4 | Stagwell Inc (STGW) | Purchase (P): 425,757 @ $4.27 · Purchase (P): 240,000 @ $4.43 | EDGAR |
| 2025-05-13 | 4 | Stagwell Inc (STGW) | Purchase (P): 200,903 @ $4.76 | EDGAR |
| 2025-04-02 | 4 | Stagwell Inc (STGW) | Grant/award (A): 3,305 @ $6.05 | EDGAR |
| 2025-01-10 | 4 | Stagwell Inc (STGW) | Grant/award (A): 3,040 @ $6.58 | EDGAR |
| 2024-10-03 | 4 | Stagwell Inc (STGW) | Grant/award (A): 2,849 @ $7.02 | EDGAR |
| 2024-08-09 | 4 | Theravance Biopharma, Inc. (TBPH) | Purchase (P): 999,800 @ $7.80 | EDGAR |
| 2024-07-03 | 4 | Stagwell Inc (STGW) | Grant/award (A): 2,933 @ $6.82 | EDGAR |
| 2024-06-14 | 4 | Stagwell Inc (STGW) | Grant/award (A): 22,762 @ $0 | EDGAR |
| 2024-06-11 | 4 | SYNOVUS FINANCIAL CORP | Sale (S): 172,889 @ $25.20 | EDGAR |
| 2024-06-07 | 4 | SYNOVUS FINANCIAL CORP | Sale (S): 6,803 @ $25.22 · Sale (S): 325 @ $25.24 · Sale (S): 20 @ $25.20 | EDGAR |
| 2024-06-04 | 4 | SYNOVUS FINANCIAL CORP | Sale (S): 200,000 @ $25.07 · Sale (S): 13,685 @ $25.23 · Sale (S): 6,278 @ $25.23 | EDGAR |
| 2024-05-03 | 4 | Theravance Biopharma, Inc. (TBPH) | Purchase (P): 999,800 @ $8.75 · Purchase (P): 499,324 @ $8.75 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1877589 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →